Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: Correlation with linear growth in GH-deficient rats

Journal of Endocrinology

Volumn 212, Issue 2, 2012, Pages 217-225

  Prickett, T C R ^a   Bothwell, J C ^a   Yandle, T G ^a   Richards, A M ^a   Espiner, E A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HUMAN GROWTH HORMONE; NATRIURETIC PEPTIDE TYPE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEART; LIVER; MALE; MUSCLE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; TIBIA; TISSUE LEVEL;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHTS AND MEASURES; BONE AND BONES; BONE DEVELOPMENT; DISEASE MODELS, ANIMAL; DWARFISM, PITUITARY; GROWTH HORMONE; GROWTH PLATE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; KIDNEY; MALE; NATRIURETIC PEPTIDE, C-TYPE; ORGAN SPECIFICITY; PROTEIN PRECURSORS; RATS; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 84856791260     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0387     Document Type: Article

References (41)

1. Bartels CF, Bukulmez H, Padayatti P, Rhee DK, van Ravenswaaij-Arts C, Pauli RM, Mundlos S, Chitayat D, Shih LY, Al-Gazali LI et al. 2004 Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. American Journal of Human Genetics 75 27-34. (doi:10.1086/422013)
2. Breur GJ, LapierreMD, Kazmierczak K, Stechuchak KM&McCabe GP 1997 The domain of hypertrophic chondrocytes in growth plates growing at different rates. Calcified Tissue International 61 418-425. (doi:10.1007/s002239900358)
3. Cameron TL, Belluoccio D, Farlie PG, Brachvogel B & Bateman JF, 2009 Global comparative transcriptome analysis of cartilage formation in vivo. BMC Developmental Biology 9 20. (doi:10.1186/1471-213X-9-20)
4. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Yet al. 2001 Dwarfism and early death in mice lacking C-type natriuretic peptide. PNAS 98 4016-4021. (doi:10.1073/pnas.071389098)
5. Cohen MM Jr, 2006 The new bone biology: pathologic, molecular, and clinical correlates. American Journal of Medical Genetics 140 2646-2706.
6. D'Ercole AJ, Stiles AD & Underwood LE, 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. PNAS 81 935-939. (doi:10.1073/pnas.81.3.935)
7. Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, DiGirolamo DJ, Kopchick JJ, Le Roith D, Trucco M & Sperling MA, 2009 Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. Journal of Biological Chemistry 284 19937-19944. (doi:10.1074/jbc.M109.014308)
8. Hunt PJ, Richards AM, Espiner EA, Nicholls MG & Yandle TG, 1994 Bioactivity and metabolism of C-type natriuretic peptide in normal man. Journal of Clinical Endocrinology and Metabolism 78 1428-1435. (doi:10.1210/jc.78.6.1428)
9. Kake T, Kitamura H, Adachi Y, Yoshioka T, Watanabe T, Matsushita H, Fujii T, Kondo E, Tachibe T, Kawase Y et al. 2009 Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. American Journal of Physiology. Endocrinology and Metabolism 297 E1339-E1348. (doi:10.1152/ajpendo.00272.2009)
10. Kimura T, Kanzaki Y, Matsumoto Y, Mandai M, Kurosaki Y & Nakayama T, 1994 Disposition of recombinant human insulin-like growth factor-I in normal and hypophysectomized rats. Biological & Pharmaceutical Bulletin 17 310-315. (doi:10.1248/bpb.17.310)
11. Koltes JE, Mishra BP, Kumar D, Kataria RS, Totir LR, Fernando RL, Cobbold R, Steffen D, Coppieters W, Georges M et al. 2009 A nonsense mutation in cGMP-dependent type II protein kinase (PRKG2) causes dwarfism in American Angus cattle. PNAS 106 19250-19255. (doi:10.1073/pnas.0904513106)
12. Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H & Wilcox WR, 2005 Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. Journal of Cell Science 118 5089-5100. (doi:10.1242/jcs.02618)
13. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S et al. 2010 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467 832-838. (doi:10.1038/nature09410)
14. McNeill BA, Barrell GK, Wellby M, Prickett TC, Yandle TG & Espiner EA, 2009 C-type natriuretic peptide forms in pregnancy: maternal plasma profiles during ovine gestation correlate with placental and fetal maturation. Endocrinology 150 4777-4783. (doi:10.1210/en.2009-0176)
15. Mendonca MC, Koles N, Doi SQ & Sellitti DF, 2010 Transforming growth factor-beta1 regulation of C-type natriuretic peptide expression in human vascular smooth muscle cells: dependence on TSC22D1. American Journal of Physiology. Heart and Circulatory Physiology 299 H2018-H2027. (doi:10. 1152/ajpheart.00656.2010)
16. Mericq V, Uyeda JA, Barnes KM, De Luca F & Baron J, 2000 Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatric Research 47 189-193. (doi:10.1203/00006450-200002000-00007)
17. Minamino N, Makino Y, Tateyama H, Kangawa K & Matsuo H, 1991 Characterization of immunoreactive human C-type natriuretic peptide in brain and heart. Biochemical and Biophysical Research Communications 179 535-542. (doi:10.1016/0006-291X(91)91404-Z)
18. Minamino N, Aburaya M, Kojima M, Miyamoto K, Kangawa K & Matsuo H, 1993 Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue. Biochemical and Biophysical Research Communications 197 326-335. (doi:10.1006/bbrc.1993.2479)
19. Moncla A, Missirian C, Cacciagli P, Balzamo E, Legeai-Mallet L, Jouve JL, Chabrol B, Le Merrer M, Plessis G, Villard L et al. 2007 A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype. HumanMutation 28 1183-1188. (doi:10.1002/humu.20611)
20. Nogami H,Watanabe T & Takeuchi T, 1992 Effect of growth hormone (GH) on the promotion of body weight gain in the spontaneous dwarf rat: a novel experimental model for isolated GH deficiency. Hormone and Metabolic Research 24 300-301. (doi:10.1055/s-2007-1003317)
21. Olney RC, 2006 C-type natriuretic peptide in growth: a new paradigm. Growth Hormone & IGF Research 16 (Suppl A) S6-S14. (doi:10.1016/j.ghir. 2006.03.016)
22. Olney RC, Prickett TC, Yandle TG, Espiner EA, Han JC & Mauras N, 2007 Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone and growth hormone. Journal of Clinical Endocrinology and Metabolism 92 4294-4298. (doi:10.1210/jc.2007-0567)
23. Olney RC, Permuy JW, Prickett TCR & Espiner EA, 2009 Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP): levels in healthy children and relation to growth velocity. Proceedings of the LWPES/ESPE 8th Joint Meeting Global Care in Pediatric Endocrinology in collaboration with APEG, APPES, JSPE and SLEP (New York, USA), Hormone Research 72 (Suppl 3) 279. (doi:10.1159/000239668)
24. Parmar KM, Larman HB, Dai G, Zhang Y,Wang ET,Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA Jr et al. 2006 Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. Journal of Clinical Investigation 116 49-58. (doi:10.1172/JCI24787)
25. Potter LR, Abbey-Hosch S & Dickey DM, 2006 Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews 27 47-72. (doi:10.1210/er.2005-0014)
26. Prickett TCR, Lynn AM, Barrell GK, Darlow BA, Cameron VA, Espiner EA, Richards AM & Yandle TG, 2005 Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatric Research 58 334-340. (doi:10.1203/01.PDR.0000169964.66260.4B)
27. Prickett TC, Barrell GK,Wellby M, Yandle TG, Richards AM & Espiner EA, 2007 Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. American Journal of Physiology. Endocrinology and Metabolism 292 E1395-E1400. (doi:10.1152/ajpendo.00469.2006)
28. Prickett TC, Dixon B, Frampton C, Yandle TG, Richards AM, Espiner EA & Darlow BA, 2008 Plasma amino-terminal pro C-type natriuretic peptide in the neonate: relation to gestational age and postnatal linear growth. Journal of Clinical Endocrinology and Metabolism 93 225-232. (doi:10.1210/jc. 2007-1815)
29. Prickett TC, Charles CJ, Yandle TG, Richards AM & Espiner EA, 2009 Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs. Peptides 30 2343-2347. (doi:10.1016/j.peptides.2009.07.023)
30. Reinecke M, Schmid AC, Heyberger-Meyer B, Hunziker EB & Zapf J, 2000 Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology 141 2847-2853. (doi:10.1210/en.141.8.2847)
31. Schouten BJ, Prickett TC, Hooper AA, Hooper GJ, Yandle TG, Richards AM & Espiner EA, 2011 Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid. Peptides 32 797-804. (doi:10.1016/j. peptides.2011.01.013)
32. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N & Imura H, 1992 Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". Journal of Clinical Investigation 90 1145-1149. (doi:10.1172/JCI115933)
33. Takei Y, Inoue K, Trajanovska S & Donald JA, 2011 B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies. General and Comparative Endocrinology 171 258-266. (doi:10.1016/j.ygcen.2011.02.021)
34. Takeuchi T, Suzuki H, Sakurai S, Nogami H, Okuma S & Ishikawa H, 1990 Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction. Endocrinology 126 31-38. (doi:10.1210/endo-126-1-31)
35. Woods A, Khan S & Beier F, 2007 C-type natriuretic peptide regulates cellular condensation and glycosaminoglycan synthesis during chondrogenesis. Endocrinology 148 5030-5041. (doi:10.1210/en.2007-0695)
36. Wu C, Wu F, Pan J, Morser J & Wu Q, 2003 Furin-mediated processing of pro-C-type natriuretic peptide. Journal of Biological Chemistry 278 25847-25852. (doi:10.1074/jbc.M301223200)
37. Yandle TG, Espiner EA, Nicholls MG & Duff , 1986 Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. Journal of Clinical Endocrinology and Metabolism 63 72-79. (doi:10.1210/jcem-63-1-72)
38. Yandle TG, Fisher S, Charles C, Espiner EA & Richards AM, 1993 The ovine hypothalamus and pituitary have markedly different distributions of C-type natriuretic peptide forms. Peptides 14 713-716. (doi:10.1016/0196-9781(93)90102-M)
39. Yasoda A, Komatsu Y, ChushoH,Miyazawa T,Ozasa A, MiuraM, Kurihara T, Rogi T, Tanaka S, Suda M et al. 2004 Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nature Medicine 10 80-86. (doi:10.1038/nm971)
40. Yasoda A, Kitamura H, Fujii T, Kondo E, Murao N, Miura M, Kanamoto N, Komatsu Y, Arai H & Nakao K, 2009 Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology 150 3138-3144. (doi:10.1210/en.2008-1676)
41. Zhang H, Landmann F, Zahreddine H, Rodriguez D, KochM& Labouesse M, 2011 A tension-induced mechanotransduction pathway promotes epithelial morphogenesis. Nature 471 99-103. (doi:10.1038/nature09765)